IR2Dx’s TIGAR™ analytical report is now available with existing laboratory assays
• IR2Dx develops independent Clinical Decision Support Tools for use by laboratory partners with commercially available test kits. Development of test kits for use with a matched decision support tool is also under development by IR2Dx.
• This valuable clinical decision support system is customized for individual laboratories and is accessed through a commercial laboratory license for use in selected major markets. The marker combinations that are analyzed are based on thousands of patient results and are covered by issued patents. To find out more about becoming a commercial laboratory partner, please see Partnership Opportunities.
• The timely indication of treatment response has proven to be valuable in understanding the current status of underlying metabolic pathways earlier and in the assessment of dose response, compliance and non-responder issues. Physicians have the opportunity to alter treatment of patients before they progress further in their disease.